SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-Q’ for 3/31/16

On:  Monday, 5/9/16, at 4:27pm ET   ·   For:  3/31/16   ·   Accession #:  944809-16-22   ·   File #:  1-33528

Previous ‘10-Q’:  ‘10-Q’ on 11/9/15 for 9/30/15   ·   Next:  ‘10-Q’ on 8/8/16 for 6/30/16   ·   Latest:  ‘10-Q’ on 11/6/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/09/16  Opko Health, Inc.                 10-Q        3/31/16   77:8.6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    593K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document and Entity Information                     HTML     41K 
13: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    105K 
14: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     31K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML     91K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statements of Comprehensive  HTML     44K 
                Loss (Unaudited)                                                 
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    134K 
                (Unaudited)                                                      
18: R7          Condensed Consolidated Statements of Cash Flows     HTML     25K 
                (Unaudited) (Parenthetical)                                      
19: R8          Business and Organization                           HTML     33K 
20: R9          Summary of Significant Accounting Policies          HTML     76K 
21: R10         Earnings (Loss) Per Share                           HTML     29K 
22: R11         Composition of Certain Financial Statement          HTML    130K 
                Captions                                                         
23: R12         Acquisitions, Investments and Licenses              HTML    116K 
24: R13         Debt                                                HTML    131K 
25: R14         Accumulated Other Comprehensive Income (Loss)       HTML     38K 
26: R15         Fair Value Measurements                             HTML    145K 
27: R16         Derivative Contracts                                HTML     53K 
28: R17         Related Party Transactions                          HTML     32K 
29: R18         Commitments and Contingencies                       HTML     36K 
30: R19         Strategic Alliances                                 HTML     43K 
31: R20         Segments                                            HTML    104K 
32: R21         Subsequent Events                                   HTML     34K 
33: R22         Summary of Significant Accounting Policies          HTML    132K 
                (Policies)                                                       
34: R23         Composition of Certain Financial Statement          HTML    131K 
                Captions (Tables)                                                
35: R24         Acquisitions, Investments and Licenses (Tables)     HTML     90K 
36: R25         Debt (Tables)                                       HTML    114K 
37: R26         Accumulated Other Comprehensive Income (Loss)       HTML     35K 
                (Tables)                                                         
38: R27         Fair Value Measurements (Tables)                    HTML    143K 
39: R28         Derivative Contracts (Tables)                       HTML     48K 
40: R29         Segments (Tables)                                   HTML     97K 
41: R30         Business and Organization (Details)                 HTML     48K 
42: R31         Summary of Significant Accounting Policies          HTML     97K 
                (Details)                                                        
43: R32         Earnings (Loss) Per Share (Details)                 HTML     34K 
44: R33         Composition of Certain Financial Statement          HTML    143K 
                Captions (Details)                                               
45: R34         Composition of Certain Financial Statement          HTML     61K 
                Captions - Changes in Goodwill (Details)                         
46: R35         Acquisitions, Investments and Licenses -            HTML     78K 
                Acquisition Narrative (Details)                                  
47: R36         Acquisitions, Investments and Licenses -            HTML     84K 
                Bio-Reference Purchase Price Allocation (Details)                
48: R37         Acquisitions, Investments and Licenses - Schedule   HTML     32K 
                of Pro Forma (Details)                                           
49: R38         Acquisitions, Investments and Licenses - EirGen     HTML     63K 
                Purchase Price Allocation (Details)                              
50: R39         Acquisitions, Investments and Licenses - Summary    HTML     36K 
                of Investments (Details)                                         
51: R40         Acquisitions, Investments and Licenses - Equity     HTML     52K 
                Method Investments Narrative (Details)                           
52: R41         Acquisitions, Investments and Licenses - Available  HTML     47K 
                for Sale Investments, Sale of Investments and                    
                Warrants and Options Narrative (Details)                         
53: R42         Acquisitions, Investments and Licenses - Variable   HTML     60K 
                Interest Entities Narrative (Details)                            
54: R43         Acquisitions, Investments and Licenses - Other      HTML     49K 
                Narrative (Details)                                              
55: R44         Debt - Narrative (Details)                          HTML    144K 
56: R45         Debt - Notes (Details)                              HTML     58K 
57: R46         Debt - Inputs Used In Lattice Model (Details)       HTML     41K 
58: R47         Debt - Fair Value Of Embedded Derivatives           HTML     29K 
                (Details)                                                        
59: R48         Debt - Lines Of Credit (Details)                    HTML     60K 
60: R49         Debt - Mortgage Notes And Other Debt (Details)      HTML     32K 
61: R50         Accumulated Other Comprehensive Income (Loss)       HTML     37K 
                (Details)                                                        
62: R51         Fair Value Measurements - Summary Of Investments    HTML     36K 
                (Details)                                                        
63: R52         Fair Value Measurements - Assets And Liabilities    HTML     60K 
                Measured At Fair Value (Details)                                 
64: R53         Fair Value Measurements - Notes (Details)           HTML     29K 
65: R54         Fair Value Measurements - Level 3 Reconciliation    HTML     38K 
                (Details)                                                        
66: R55         Fair Value Measurements - Narrative (Details)       HTML     34K 
67: R56         Derivative Contracts - Balance Sheet Component      HTML     40K 
                (Details)                                                        
68: R57         Derivative Contracts - Derivative Gains (Losses)    HTML     32K 
                (Details)                                                        
69: R58         Related Party Transactions (Details)                HTML    111K 
70: R59         Commitments and Contingencies (Details)             HTML     37K 
71: R60         Strategic Alliances (Details)                       HTML     96K 
72: R61         Segments - Narrative (Details)                      HTML     42K 
73: R62         Segments - Operations and Assets Information        HTML     74K 
                (Details)                                                        
74: R63         Subsequent Events (Details)                         HTML     63K 
76: XML         IDEA XML File -- Filing Summary                      XML    136K 
75: EXCEL       IDEA Workbook of Financial Reports                  XLSX    108K 
 6: EX-101.INS  XBRL Instance -- opk-20160331                        XML   2.50M 
 8: EX-101.CAL  XBRL Calculations -- opk-20160331_cal                XML    234K 
 9: EX-101.DEF  XBRL Definitions -- opk-20160331_def                 XML   1.06M 
10: EX-101.LAB  XBRL Labels -- opk-20160331_lab                      XML   2.02M 
11: EX-101.PRE  XBRL Presentations -- opk-20160331_pre               XML   1.28M 
 7: EX-101.SCH  XBRL Schema -- opk-20160331                          XSD    190K 
77: ZIP         XBRL Zipped Folder -- 0000944809-16-000022-xbrl      Zip    296K 




        
Filing Submission 0000944809-16-000022 – SGML Text

Original SGML Text submitted by:  Opko Health, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 11:35:04.2am ET